Scarica l'app Stockscreener
7.33
1.21%
-0.09
Dopo l'orario di chiusura:
7.38
0.05
+0.68%
Niagen Bioscience Inc Borsa (NAGE) Ultime notizie
Applying sector rotation models to Niagen Bioscience Inc.Insider Buying & Step-by-Step Swing Trade Plans - newser.com
What moving averages say about Niagen Bioscience Inc.Quarterly Risk Review & Low Risk High Reward Ideas - newser.com
Can Niagen Bioscience Inc. stock attract ESG capital inflowsJuly 2025 PreEarnings & Free Reliable Trade Execution Plans - Trung tâm Dự báo KTTV quốc gia
Is Niagen Bioscience Inc. a candidate for recovery playJuly 2025 Closing Moves & Daily Momentum Trading Reports - newser.com
Is Niagen Bioscience Inc. stock undervalued vs historical averagesSell Signal & Fast Exit and Entry Strategy Plans - newser.com
Will Niagen Bioscience Inc. stock go up soonWeekly Market Outlook & Accurate Technical Buy Alerts - newser.com
Tools to assess Niagen Bioscience Inc.’s risk profileMarket Activity Report & Daily Profit Focused Screening - newser.com
National Advertising Division Finds Certain Reus Cata-Kor NAD+ Claims Supported; Recommends Others Be Modified or Discontinued - GlobeNewswire Inc.
How Niagen Bioscience Inc. (OCD1) stock trades pre earnings2025 Support & Resistance & Real-Time Stock Movement Alerts - newser.com
What earnings revisions data tells us about Niagen Bioscience Inc.Weekly Trend Summary & Safe Capital Growth Plans - newser.com
Is NAGE's Pullback A Second Chance For Investors? - RTTNews
Niagen Bioscience's (NAGE) Hold (C) Rating Reiterated at Weiss Ratings - MarketBeat
Owning 37% shares,institutional owners seem interested in Niagen Bioscience, Inc. (NASDAQ:NAGE), - Yahoo Finance
What is Roth Capital’s Estimate for NAGE Q3 Earnings? - Defense World
When is the best time to exit Niagen Bioscience Inc.Global Markets & Risk Controlled Daily Plans - newser.com
Pattern recognition hints at Niagen Bioscience Inc. upsideJuly 2025 Market Mood & Safe Swing Trade Setups - newser.com
Full technical analysis of Niagen Bioscience Inc. stockShare Buyback & Capital Protection Trading Alerts - newser.com
Niagen Bioscience raises 2025 sales outlook on NAD+ market growth By Investing.com - Investing.com Nigeria
Niagen Bioscience Raises 2025 Sales Outlook Amid FDA Ruling - TipRanks
Niagen Bioscience, Inc. Provides Net Sales Guidance for the Full-Year 2025 - MarketScreener
Niagen Bioscience (NAGE) Gains Attention with FDA's NMN Ruling R - GuruFocus
Niagen Bioscience (NAGE) Boosts 2025 Sales Forecast - GuruFocus
Niagen Bioscience increases full year 2025 net sales outlook to 25% to 30% year-over-year growth - MarketScreener
Niagen Bioscience raises 2025 sales outlook on NAD+ market growth - Investing.com
Niagen Bioscience Increases Full Year 2025 Net Sales Outlook to 25% to 30% Year-Over-Year Growth - Business Wire
What margin trends mean for Niagen Bioscience Inc. stockEarnings Beat & Technical Buy Zone Confirmation - newser.com
Is Niagen Bioscience Inc. reversing from oversold territoryJuly 2025 Selloffs & Trade Opportunity Analysis Reports - newser.com
Roth Capital Issues Pessimistic Estimate for NAGE Earnings - Defense World
A Fresh Look at Niagen Bioscience (NAGE) Valuation After Nationwide iCRYO Distribution Expansion - Sahm
Roth Capital Lowers Earnings Estimates for Niagen Bioscience - MarketBeat
Niagen Bioscience, Inc.'s (NASDAQ:NAGE) 25% Cheaper Price Remains In Tune With Revenues - simplywall.st
Niagen Bioscience, Inc.'s (NASDAQ:NAGE) Stock Retreats 25% But Revenues Haven't Escaped The Attention Of Investors - 富途牛牛
What macro factors could drive Niagen Bioscience Inc. (OCD1) stock higher2025 Market WrapUp & Precise Buy Zone Identification - newser.com
Niagen Bioscience's Pharmaceutical-Grade Niagen IV and Injections Now Available at over 50 iCRYO Clinics and More than 900 Total Clinics Nationwide - MarketScreener
1.84%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):